Samy Tadros
Corporate Officer/Principal bij TANGO THERAPEUTICS, INC.
Profiel
Samy Tadros is currently the Head of Business Development at Tango Therapeutics, Inc. He previously worked as the Executive Director of Business Development at Celgene Corp.
Tadros has an undergraduate degree from Concordia University Chicago, an MBA from Fairleigh Dickinson University, and a graduate degree from Temple University School of Pharmacy.
Actieve functies van Samy Tadros
| Bedrijven | Functie | Begin |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Eerdere bekende functies van Samy Tadros
| Bedrijven | Functie | Einde |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
Opleiding van Samy Tadros
| Concordia University Chicago | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
| Temple University School of Pharmacy | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TANGO THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
